Literature DB >> 23620316

Cardiac characterization of mdx mice using high-resolution doppler echocardiography.

Abdallah Fayssoil1, Gilles Renault, Nicolas Guerchet, Carmen Marchiol-Fournigault, Françoise Fougerousse, Isabelle Richard.   

Abstract

OBJECTIVES: Duchenne muscular dystrophy is an X-linked neuromuscular disorder. The heart is traditionally involved, leading to heart failure. The mdx mouse is a natural animal model of the disease. We conducted a prospective study to analyze left ventricular (LV) function in mdx mice at different ages using high-resolution Doppler echocardiography.
METHODS: Echocardiography was performed with a 30-MHz cardiac probe. Wild-type and mdx mice were scanned at 10 and 12 months. We measured the interventricular septal wall thickness, posterior wall thickness, and LV diameter in systole and diastole. The LV shortening fraction, LV ejection fraction, and LV mass were then calculated.
RESULTS: At 10 months, the shortening fractions in mdx and wild-type mice were relatively close (29% ± 5% versus 25% ± 4%). We found a significant difference in the posterior wall thickness change (40% ± 12% in mdx versus 28% ± 10% in wild-type; P = .048). The LV mass/body weight ratio was higher in mdx than wild-type mice (3.67 ± 0.25 versus 3.39 ± 0.26; P = .05). At 12 months, the LV mass was elevated in mdx mice compared to wild-type (152 ±16 versus 135 ± 3.7 mg; P = .04). The diastolic posterior wall thickness change was decreased in mdx mice at 12 months compared to wild-type (21% ± 7% versus 33% ± 4%; P = .01). The LV ejection fraction was not statistically different between mdx and wild-type mice (50% ± 6% versus 54% ± 2%).
CONCLUSIONS: Ten-month-old mdx mice had a significantly higher posterior wall thickness than wild-type mice, but it was not significant at 12 months. In 12-month-old mdx mice, the posterior wall thickness change was significantly lower, and the LV mass was significantly higher. These findings indicate the role of LV function in the early stages of Duchenne muscular dystrophy.

Entities:  

Mesh:

Year:  2013        PMID: 23620316     DOI: 10.7863/ultra.32.5.757

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  16 in total

Review 1.  Mechano-chemo-transduction in cardiac myocytes.

Authors:  Ye Chen-Izu; Leighton T Izu
Journal:  J Physiol       Date:  2017-03-10       Impact factor: 5.182

2.  Sex differences in the involvement of skeletal and cardiac muscles in myopathic Ano5-/- mice.

Authors:  Steven Foltz; Fang Wu; Nasab Ghazal; Jennifer Q Kwong; H Criss Hartzell; Hyojung J Choo
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-12       Impact factor: 4.249

3.  Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.

Authors:  Maria Siemionow; Paulina Langa; Sonia Brodowska; Katarzyna Kozlowska; Kristina Zalants; Katarzyna Budzynska; Ahlke Heydemann
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 6.692

Review 4.  Small mammalian animal models of heart disease.

Authors:  Paula Camacho; Huimin Fan; Zhongmin Liu; Jia-Qiang He
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15

5.  Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Nadia Milad; Zoe White; Arash Y Tehrani; Stephanie Sellers; Fabio M V Rossi; Pascal Bernatchez
Journal:  Skelet Muscle       Date:  2017-09-12       Impact factor: 4.912

6.  Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.

Authors:  Sarka Jelinkova; Yvonne Sleiman; Petr Fojtík; Franck Aimond; Amanda Finan; Gerald Hugon; Valerie Scheuermann; Deborah Beckerová; Olivier Cazorla; Marie Vincenti; Pascal Amedro; Sylvain Richard; Josef Jaros; Petr Dvorak; Alain Lacampagne; Gilles Carnac; Vladimir Rotrekl; Albano C Meli
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

Review 7.  Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Authors:  Ashling Holland; Kay Ohlendieck
Journal:  Biomed Res Int       Date:  2014-03-20       Impact factor: 3.411

8.  Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.

Authors:  Michelle S Parvatiyar; Jamie L Marshall; Reginald T Nguyen; Maria C Jordan; Vanitra A Richardson; Kenneth P Roos; Rachelle H Crosbie-Watson
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

9.  Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice.

Authors:  Anthony Blaeser; Hiroyuki Awano; Bo Wu; Qi-Long Lu
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

10.  NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model.

Authors:  Jennifer M Peterson; David J Wang; Vikram Shettigar; Steve R Roof; Benjamin D Canan; Nadine Bakkar; Jonathan Shintaku; Jin-Mo Gu; Sean C Little; Nivedita M Ratnam; Priya Londhe; Leina Lu; Christopher E Gaw; Jennifer M Petrosino; Sandya Liyanarachchi; Huating Wang; Paul M L Janssen; Jonathan P Davis; Mark T Ziolo; Sudarshana M Sharma; Denis C Guttridge
Journal:  Nat Commun       Date:  2018-08-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.